Patents Assigned to Georgetown University
-
Patent number: 12759980Abstract: Provided herein are compositions and methods for treating or preventing a neurodegenerative disease, a neurodevelopmental disease, a myodegenerative disease, a prion disease, a lysosomal storage disease or cancer in a subject.Type: GrantFiled: January 29, 2021Date of Patent: October 13, 2026Assignee: GEORGETOWN UNIVERSITYInventors: Charbel Moussa, Christian Wolf, Balaraman Kaluvu
-
Patent number: 12749609Abstract: Embodiments may provide the realization of strong Dzyaloshinskii-Moriya Interaction (DMI) and perpendicular magnetic anisotropy (PMA) induced by chemisorbed species on a ferromagnetic layer. For example, in an embodiment, an apparatus for generating a Dzyaloshinskii-Moriya interaction may comprise a ferromagnet comprising a single layer or multi-layers of materials made of metal, oxide or other types of magnetic films, and a substance chemisorbed on a surface of the ferromagnet to induce the Dzyaloshinskii-Moriya interaction or the perpendicular magnetic anisotropy at the interface between chemisorbed species and ferromagnet. These induced effects may be used to manipulate spin textures such as switching of domain wall chirality and writing/deleting of magnetic skyrmions, which are relevant for spintronics, magneto-ionics as well as gas sensing.Type: GrantFiled: August 13, 2020Date of Patent: September 29, 2026Assignees: Georgetown University, The Regents of the University of CaliforniaInventors: Gong Chen, Kai Liu, Andreas Schmid
-
Patent number: 12749330Abstract: Technologies are described for reconstructing physical objects which are preserved or represented in pictorial records. The reconstructed models can be three-dimensional (3D) point clouds and can be compared to existing physical models and/or other reconstructed models based on physical geometry. The 3D point cloud models can be encoded into one or more latent space feature vector representations which can allow both local and global geometric properties of the object to be described. The one or more feature vector representations of the object can be used individually or in combination with other descriptors for retrieval and classification tasks. Neural networks can be used in the encoding of the one or more feature vector representations.Type: GrantFiled: July 18, 2024Date of Patent: September 29, 2026Assignee: Georgetown UniversityInventors: Cristopher Flagg, Ophir Frieder
-
Publication number: 20260286302Abstract: A unique CD8 T cell central memory subtype obtained by treatment of CD8 T cells with a poly(ADP-ribose) polymerase (PARP) inhibitor (PARPi) is described. These cells, referred to as super-central memory CD8 T cells (TCMsup) or PARPi-induced memory T cells, are significantly more efficient for cancer therapy than traditional central memory T cells (TCM) generated by tumor antigens. Methods of using the TCMsup cells for enhancing cancer immunotherapy, enhancing vaccine-induced immunity, and treating cancer are described.Type: ApplicationFiled: April 12, 2024Publication date: September 24, 2026Applicant: Georgetown UniversityInventors: Samir N. Khleif, Seema Gupta, Wael Traboulsi
-
Patent number: 12744030Abstract: Embodiments of the present systems and methods may provide techniques for synthesizing speech in any voice in any language in any accent. For example, in an embodiment, a text-to-speech conversion system may comprise a text converter adapted to convert input text to at least one phoneme selected from a plurality of phonemes stored in memory, a machine-learning model storing voice patterns for a plurality of individuals and adapted to receive the at least one phoneme and an identity of a speaker and to generate acoustic features for each phoneme, and a decoder adapted to receive the generated acoustic features and to generate a speech signal simulating a voice of the identified speaker in a language.Type: GrantFiled: May 28, 2024Date of Patent: September 22, 2026Assignee: Georgetown UniversityInventors: Joe Garman, Ophir Frieder
-
Patent number: 12742200Abstract: Provided are methods and compositions useful for assessing the length of telomeres. The disclosed methods and compositions are amenable to performance as a high-throughput method to assess telomere length (TL) and TL constitution using genomic DNA. Also provided are methods for diagnosing a telomere-related condition or disease in a subject, assessing general health and/or aging of a subject, establishing a relationship between telomere constitution and cancer and/or aging-related disease, assessing exposure to harmful substances and/or stresses of a subject, assessing response to a drug or drugs treatment of a subject, assessing disease risk of a subject, and assessing clinical outcome of a subject who is suffering from a disease/diseases. The methods are useful in studies of individuals and populations.Type: GrantFiled: July 30, 2020Date of Patent: September 22, 2026Assignee: Georgetown UniversityInventor: Yun-Ling Zheng
-
Patent number: 12724014Abstract: The present application relates to an analytical method that includes providing a sample potentially containing a chiral analyte that can exist in stereoisomeric forms, providing certain probes; and providing an indicator. The sample is contacted with an excess of the probe under conditions to permit irreversible covalent binding of the probe to the analyte, if present in the sample. The sample is contacted with the indicator under conditions to permit covalent binding of the indicator to any excess probe that is not bound to the analyte. Based on any binding that occurs between the analyte and probe, the absolute configuration of the analyte in the sample and/or the enantiomeric composition of the analyte in the sample using a chiroptical technique is/are determined. Based on any binding that occurs between the indicator and probe, the concentration of the analyte in the sample is determined using a non-chiroptical technique.Type: GrantFiled: March 8, 2021Date of Patent: September 1, 2026Assignee: GEORGETOWN UNIVERSITYInventors: Christian Wolf, Yushra F. Thanzeel, Balaraman Kaluvu
-
Patent number: 12711408Abstract: A hypotheses generation and event recognition system that enables event recognition by analyzing documents to construct one or more qualitative metrics (e.g., frequency of keywords, changes in sentiment, occurrence of ontological terms, evolution of topics, etc.), establishing a baseline for the qualitative metric(s), and outputting changes to that baseline for display. In aggregate, those qualitative metrics comprise temporal and/or spatial signals that, when combined, define signatures of events of interest. Accordingly, the user and/or the system may identify an event of interest based on the change in baseline. The system may further provide functionality to generate hypotheses by coding data according to an ontology, populating an ontology space, and using an optimization algorithm to rank points or neighborhoods in the coded ontology space.Type: GrantFiled: January 24, 2024Date of Patent: August 18, 2026Assignee: GEORGETOWN UNIVERSITYInventors: David M. Hartley, Nili S. Yossinger, Ophir Frieder
-
Patent number: 12690782Abstract: A gait analysis system, which includes a neural network with a recurrent neural network layer and a fully connected layer, that receives sensor data indicative of an individual's gait and outputs an assessment regarding the individual's health. The neural network is trained using training data indicative of abnormal gaits and normal gaits. To analyze the training data and the sensor data, the recurrent neural network layer parses each piece of data into a series of windows and analyzes each window in series to generate a context vector characterizing each window and the previously analyzed windows. The fully connected layer, having been trained to differentiate between normal gaits and abnormal gaits based on context vectors characterizing the training data, is used to generate a final assessment characterizing the user gate as normal or abnormal using one or more of the context vectors characterizing the sensor data.Type: GrantFiled: January 26, 2023Date of Patent: July 28, 2026Assignee: Georgetown UniversityInventors: Gholam Motamedi, Ophir Frieder, Cristopher Flagg, Jian-Young Wu
-
Patent number: 12694956Abstract: A method and system for merging healthcare records across multiple locations is presented. The method first creates anonymized healthcare records by removing personally identifiable information. The method then converts each record into an embedding and appends a site locator identifying only the originator of the healthcare record. Then these embeddings are combined with similarly processed embeddings from multiple sites to create a merged database of embeddings derived from patient healthcare records. A classifier is trained to predict likely outcomes based on the merged database of embeddings. For a new patient, the corresponding healthcare record is converted to an embedding and the merged database of embeddings is then searched for a most similar patient and a treatment is recommended for the new patient, based on the prediction of the classifier.Type: GrantFiled: May 3, 2023Date of Patent: July 28, 2026Assignee: GEORGETOWN UNIVERSITYInventors: Ophir Frieder, Dinesh Maheshwari
-
Patent number: 12685757Abstract: Provided herein are methods of stabilizing blood pressure in severe sepsis/septic shock and other types of distributive shock using TRPV1 agonists. Also provided are pharmaceutical formulations for increasing blood pressure in septic shock the formulation including at least one TRPV1 agonist in a dosage form for parenteral administration, wherein the TRPV1 agonist is selected from capsaicin, daphnane TRPV1 agonists, vanillotoxin, N-oleoyl dopamine, N-arachidonyl dopamine, BrP-LPA, and derivatives and analogues thereof. Also provided are TRPV1 agonists co-lyophilized with adrenergic agonists and/or angiotensins in a dosage form for reconstitution and parenteral administration.Type: GrantFiled: August 20, 2020Date of Patent: July 21, 2026Assignee: GEORGETOWN UNIVERSITYInventors: Gerard P. Ahern, Thieu X. Phan
-
Patent number: 12678425Abstract: A combinatorial method for treating against, or at least inhibiting or suppressing, the proliferation of an internal ribosome entry site utilizing virus (IRES-utilizing virus) in a host in need of treatment involves administering the host a compound, a tautomer, or a pharmaceutically acceptable salt thereof, in an amount effective for inhibiting replication of the IRES-utilizing virus in cells, wherein the compound is represented by the formula: wherein each R1 is independent of the other and represents a halogen atom selected from the group consisting of bromo, chloro, fluoro and iodo; and either separately administering another anti-viral drug and/or pro-drug to the anti-viral drug or co-administering the anti-viral drug and/or the pro-drug with the compound, its tautomer, or its pharmaceutically acceptable salt.Type: GrantFiled: April 27, 2020Date of Patent: July 14, 2026Assignees: Howard University, GEORGETOWN UNIVERSITYInventors: Hemayet Ullah, Sivanesan Dakshanamurthy
-
Publication number: 20260191880Abstract: Provided herein are methods for treating a cholecystokinin (CCK) receptor-expressing cancerous tumor in a subject. Also provided are methods for increasing sensitivity of a (CCK) receptor-expressing cancerous tumor in a subject to immunotherapy.Type: ApplicationFiled: January 17, 2025Publication date: July 9, 2026Applicant: GEORGETOWN UNIVERSITYInventors: Jill P. SMITH, Louis WEINER, Sandra JABLONSKI, Sandeep NADELLA, Shangzi WANG
-
Publication number: 20260167715Abstract: Provided herein are methods of targeting PD-1+CD38hiCD8+ T cells to reduce apoptosis of white blood cells (e.g., lymphocytes). Further provided are methods of inducing apoptosis of white blood cells in a subject by using adoptive cell therapy with PD-1+CD38hiCD8+ T cells.Type: ApplicationFiled: October 26, 2023Publication date: June 18, 2026Applicant: GEORGETOWN UNIVERSITYInventors: Pankaj N. GAUR, Samir KHLEIF, Seema GUPTA, Vivek VERMA
-
Publication number: 20260147126Abstract: A method is provided to reduce the counting times in radiation detection systems using machine learning, wherein the method comprises: receiving output data from a detector which is to detect a target material from a target body; analyzing the output data; identifying a material of interest from the analyzed output data; and controlling a source of the target material to prevent the source from harming the target body. An apparatus is also provided which comprises: a detector to detect radiation and to provide an output data in real-time; and a processor coupled to the detector, wherein the processor is to: receive the output data; analyze the output data; identify a material of interest from the analyzed output data; and control a source of the target material.Type: ApplicationFiled: April 14, 2025Publication date: May 28, 2026Applicants: Oregon State University, Georgetown UniversityInventors: Ophir Frieder, Steven Richard Reese, Jessica Ryan Curtis
-
Patent number: 12629355Abstract: A method for treating against, or at least inhibiting or suppressing, the proliferation of a cancer involves administering a compound, a tautomer, or a pharmaceutically acceptable salt thereof, in an amount effective for inhibiting metastasis of cancer cells, wherein the compound is represented by the formula (1): wherein each R1 independent of the other and represents a halogen atom selected from the group consisting of bromo, chloro, fluoro and iodo.Type: GrantFiled: March 25, 2020Date of Patent: May 19, 2026Assignees: Howard University, GEORGETOWN UNIVERSITYInventors: Hemayet Ullah, Sivanesan Dakshanamurthy
-
Patent number: 12619934Abstract: A specialized computing environment that includes hardware and data security features to enable competitive organizations to co-analyze proprietary data without revealing the underlying proprietary data to unauthorized users. Proprietary data are stored in volatile memory, which may be automatically erased according to pre-stored criteria. The analysis is performed automatically by a processing unit without human intervention. Analytical results are sanitized (e.g., using data masking) to prevent the analytical result from being tracible to any particular data source. Sanitized analytical results are output without outputting the underlying proprietary data (except to users authorized to validate analytical results). The computing environment is enclosed within a secure enclosure (e.g.Type: GrantFiled: May 9, 2023Date of Patent: May 5, 2026Assignee: Georgetown UniversityInventors: David Hartley, Ophir Frieder
-
Publication number: 20260083724Abstract: Compounds comprising a PAX3::FOXO1 fusion protein binding moiety, a bivalent linker, and an E3 ubiquitin ligase binding moiety. The compounds can be used to reduce PAX3::FOXO1 protein levels in a subject with fusion-positive rhabdomyosarcoma (FP-RMS), to ubiquitinate a PAX3::FOXO1 fusion protein in a cell, to treat FP-RMS in a subject in need thereof, and/or to treat a disease caused by the overexpression of PAX3::FOXO1 protein in a subject in need thereof.Type: ApplicationFiled: September 26, 2025Publication date: March 26, 2026Applicant: Georgetown UniversityInventors: Aykut Üren, Jeffrey A. Toretsky
-
Patent number: 12521659Abstract: A metal foam-based filtration system and method for removing sub-micron particles and contaminants from a gas or fluid flow with the use of ultralow density metal nanowire meshes that have nanometer to micron scale pores for trapping air/fluid-borne particulates. Filters can use metal foams and coated metal foams alone or in tandem. The size and density of pores in the foam can be adjusted with synthesis conditions. Foams with pore size gradients promote the trapping of different sized particulates at different regions of a foam. Multiple rounds of electrodeposition may be applied to increase the surface area and curvature of a nanowire mesh and strengthen the mesh to make it self-supporting, free-standing and capable of supporting a much heavier mass without collapse. A metal and/or a coated metal foam can act as a catalyst or substrate for absorption or adsorption to capture target particles and/or contaminants.Type: GrantFiled: April 29, 2021Date of Patent: January 13, 2026Assignee: Georgetown UniversityInventors: Kai Liu, James D. Malloy
-
Patent number: 12517111Abstract: Systems and methods for characterizing cancer cells are disclosed. In certain embodiments, the systems and methods involve coating a first chamber with ECM material and adding a first plurality of cells to the first chamber, adding media to a second chamber, and adding a second plurality of cells and media to a third chamber. The first, second, and third chambers are then clipped together to form a chamber array. The chamber array is mounted to an electric cell impedance sensing reader and impedance readouts of cell invasion are collected from the electric array at time intervals. Cells detected to invade into the second chamber are extracted and characterized.Type: GrantFiled: September 9, 2019Date of Patent: January 6, 2026Assignee: GEORGETOWN UNIVERSITYInventors: Anton Wellstein, Ghada M. Sharif, Makarand Paranjape, Leon Der